A new artificial intelligence (AI) model has just achieved human-level results on a test designed to measure “general intelligence.”
On December 20, OpenAI’s o3 system scored 85% on the ARC-AGI benchmark, well above the previous AI best score of 55% and on par with the average human score. It also scored well on a very difficult mathematics test.
Creating artificial general intelligence, or AGI, is the stated goal of all the major AI research labs. At first glance, OpenAI appears to have at least made a significant step towards this goal.
While skepticism remains, many AI researchers and developers feel something just changed. For many, the prospect of AGI now seems more real, urgent and closer than anticipated. Are they right?
Generalization and intelligence
To understand what the o3 result means, you need to understand what the ARC-AGI test is all about. In technical terms, it’s a test of an AI system’s “sample efficiency” in adapting to something new—how many examples of a novel situation the system needs to see to figure out how it works.
An AI system like ChatGPT (GPT-4) is not very sample efficient. It was “trained” on millions of examples of human text, constructing probabilistic “rules” about which combinations of words are most likely.
The result is pretty good at common tasks. It is bad at uncommon tasks, because it has less data (fewer samples) about those tasks.
Until AI systems can learn from small numbers of examples and adapt with more sample efficiency, they will only be used for very repetitive jobs and ones where the occasional failure is tolerable.
The ability to accurately solve previously unknown or novel problems from limited samples of data is known as the capacity to generalize. It is widely considered a necessary, even fundamental, element of intelligence.
Grids and patterns
The ARC-AGI benchmark tests for sample efficient adaptation using little grid square problems like the one below. The AI needs to figure out the pattern that turns the grid on the left into the grid on the right.

Each question gives three examples to learn from. The AI system then needs to figure out the rules that “generalize” from the three examples to the fourth.
These are a lot like the IQ tests sometimes you might remember from school.
Weak rules and adaptation
We don’t know exactly how OpenAI has done it, but the results suggest the o3 model is highly adaptable. From just a few examples, it finds rules that can be generalized.
To figure out a pattern, we shouldn’t make any unnecessary assumptions, or be more specific than we really have to be. In theory, if you can identify the “weakest” rules that do what you want, then you have maximized your ability to adapt to new situations.
What do we mean by the weakest rules? The technical definition is complicated, but weaker rules are usually ones that can be described in simpler statements.
In the example above, a plain English expression of the rule might be something like: “Any shape with a protruding line will move to the end of that line and ‘cover up’ any other shapes it overlaps with.”
Searching chains of thought?
While we don’t know how OpenAI achieved this result just yet, it seems unlikely they deliberately optimized the o3 system to find weak rules. However, to succeed at the ARC-AGI tasks, it must be finding them.
We do know that OpenAI started with a general-purpose version of the o3 model (which differs from most other models, because it can spend more time “thinking” about difficult questions) and then trained it specifically for the ARC-AGI test.
French AI researcher Francois Chollet, who designed the benchmark, believes o3 searches through different “chains of thought” describing steps to solve the task. It would then choose the “best” according to some loosely defined rule, or “heuristic.”
This would be “not dissimilar” to how Google’s AlphaGo system searched through different possible sequences of moves to beat the world Go champion.
You can think of these chains of thought like programs that fit the examples. Of course, if it is like the Go-playing AI, then it needs a heuristic, or loose rule, to decide which program is best.
There could be thousands of different seemingly equally valid programs generated. That heuristic could be “choose the weakest” or “choose the simplest.”
However, if it is like AlphaGo then they simply had an AI create a heuristic. This was the process for AlphaGo. Google trained a model to rate different sequences of moves as better or worse than others.
What we still don’t know
The question then is, is this really closer to AGI? If that is how o3 works, then the underlying model might not be much better than previous models.
The concepts the model learns from language might not be any more suitable for generalization than before. Instead, we may just be seeing a more generalizable “chain of thought” found through the extra steps of training a heuristic specialized to this test. The proof, as always, will be in the pudding.
Almost everything about o3 remains unknown. OpenAI has limited disclosure to a few media presentations and early testing to a handful of researchers, laboratories and AI safety institutions.
Truly understanding the potential of o3 will require extensive work, including evaluations, an understanding of the distribution of its capacities, how often it fails and how often it succeeds.
When o3 is finally released, we’ll have a much better idea of whether it is approximately as adaptable as an average human.
If so, it could have a huge, revolutionary, economic impact, ushering in a new era of self-improving accelerated intelligence. We will require new benchmarks for AGI itself and serious consideration of how it ought to be governed.
If not, then this will still be an impressive result. However, everyday life will remain much the same.
News
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]















